The neutral borosilicate medicinal glass project designed and developed by Kibing Group has broken the global technology monopoly of Germany, the US and Japan, and reduced production costs for downstream enterprises.

 

The Phase I and Phase II have been put into production with an investment of 600 million yuan. Predictably, the annual output value will reach 200 million yuan after the project reaches the full capacity and over 300 workers will be needed. 

 

It was awarded an excellent industrial project in Chenzhou City in 2021.